×
About 5,238 results

ALLMedicine™ Hyperkalemia Center

Research & Reviews  1,469 results

Pseudohypoaldosteronism
https://emedicine.medscape.com/article/924100-print

Aug 5th, 2022 - Background Pseudohypoaldosteronism (PHA) comprises a heterogeneous group of disorders of electrolyte metabolism characterized by an apparent state of renal tubular unresponsiveness or resistance to the action of aldosterone. It is manifested by hy...

Pseudohypoaldosteronism
https://emedicine.medscape.com/article/924100-overview

Aug 5th, 2022 - Background Pseudohypoaldosteronism (PHA) comprises a heterogeneous group of disorders of electrolyte metabolism characterized by an apparent state of renal tubular unresponsiveness or resistance to the action of aldosterone. It is manifested by hy...

Pseudohypoaldosteronism
http://emedicine.medscape.com/article/924100-overview

Aug 5th, 2022 - Background Pseudohypoaldosteronism (PHA) comprises a heterogeneous group of disorders of electrolyte metabolism characterized by an apparent state of renal tubular unresponsiveness or resistance to the action of aldosterone. It is manifested by hy...

A case of severe systemic type 1 pseudohypoaldosteronism with 10 years of evolution.
https://doi.org/10.1515/jpem-2022-0201
Journal of Pediatric Endocrinology & Metabolism : JPEM; Coelho Almeida A, Bastos Gomes M et. al.

Aug 4th, 2022 - Type 1 pseudohypoaldosteronism (PHA-1) is a rare genetic syndrome of unresponsiveness to aldosterone and presents in the neonatal period with hyperkalemia, hyponatremia and metabolic acidosis. The mortality rate can be high and multidisciplinary t...

The Association Between Tacrolimus Levels and Hyperkalemia in Allograft Recipients Who ...
https://doi.org/10.12659/AOT.935607
Annals of Transplantation; Griffis OL, Thai SQ et. al.

Aug 3rd, 2022 - BACKGROUND Tacrolimus, a calcineurin inhibitor, is the cornerstone of immunosuppressive strategies in transplantation. Other studies have concluded that hyperkalemia correlates with tacrolimus therapy, though the impact is poorly understood. In 2 ...

see more →

Guidelines  1 results

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood...
https://doi.org/10.1016/j.cjca.2016.02.066
The Canadian Journal of Cardiology; Leung AA, Nerenberg K et. al.

Apr 28th, 2016 - Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force provides annually updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present 4 ne...

see more →

Drugs  167 results see all →

Clinicaltrials.gov  136 results

Tracking Treatment Pathways in Adult Patients With Hyperkalemia.
https://clinicaltrials.gov/ct2/show/NCT05408039

Aug 3rd, 2022 - This study is a multinational, observational, prospective, longitudinal, cohort study that will include primary and secondary data collection. Secondary data, collected as per routine clinical practice will be extracted from electronic health reco...

Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
https://clinicaltrials.gov/ct2/show/NCT04676646

Jul 29th, 2022 - REALIZE-K is a Phase 4, multinational, multicenter, double-blind, placebo-controlled, randomized-withdrawal, parallel-group study that includes the following 3 phases: screening, 4-6 week open-label run-in phase where sodium zirconium cyclosilicat...

Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans
https://clinicaltrials.gov/ct2/show/NCT05145309

Jul 27th, 2022 - This is a double blind, randomized crossover trial comprising two phases: Placebo Phase (microcrystalline cellulose in water) and KMgCit Phase (KMgCit powder in water) to investigate the use of KMgCit in lowering blood pressure and reducing arteri...

Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)
https://clinicaltrials.gov/ct2/show/NCT04847232

Jul 21st, 2022 - This is an international, multicenter, event-driven, randomized, double-blind, parallel group, placebo-controlled study, evaluating the utility of SZC versus placebo to reduce the incidence of sudden cardiac death (SCD), stroke, and arrhythmia-rel...

Dietary Potassium Liberalization in Pre-Dialysis Patients
https://clinicaltrials.gov/ct2/show/NCT05090865

Jul 21st, 2022 - The kidney is a primary site of potassium regulation in the body. Hyperkalemia, elevated serum potassium, occurs in approximately 10% of patients with chronic kidney disease (CKD) and is associated with elevated all-cause mortality. To minimize th...

see more →

News  321 results

Aug 5, 2022 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/978646

Aug 5th, 2022 - Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast on Apple Podcasts, Spotify, or your preferred podcast provider...

Potassium Abnormalities Boost Hospital Visits for Kidney Disease
https://www.medscape.com/viewarticle/972652

Apr 25th, 2022 - Patients with advanced chronic kidney disease (CKD) are at higher risk of hospitalization or requiring an emergency room (ER) visit in the short-term if they have abnormal potassium levels, a nationally representative cohort of US veterans with ad...

DIAMOND: Adding Patiromer Helps Optimize HF Meds, Foils Hyperkalemia
https://www.medscape.com/viewarticle/971616

Apr 5th, 2022 - Several of the core meds for patients with heart failure with reduced ejection fraction (HFrEF) come with a well-known risk of causing hyperkalemia, to which many clinicians respond by pulling back on dosing or withdrawing the culprit drug. But ac...

Fast Five Quiz: Emergency Management of Hyperkalemia
https://reference.medscape.com/viewarticle/970032

Mar 23rd, 2022 - Hyperkalemia is defined as a serum potassium concentration greater than approximately 5.0-5.5 mEq/L. Hyperkalemia can be difficult to diagnose clinically because symptoms may be vague or absent; many individuals are asymptomatic. When present, sym...

An Academic Hospitalist–Run Outpatient Paracentesis Clinic
https://www.mdedge.com/fedprac/article/252436/hospital-medicine/academic-hospitalist-run-outpatient-paracentesis-clinic
Lawrence D. Gerber, MD, Gaetan Sgro, MD et. al.

Mar 4th, 2022 - Cirrhosis is the most common cause of ascites in the United States. In patients with compensated cirrhosis, the 10-year probability of developing ascites is 47%.

see more →

Patient Education  1 results see all →